Introduction
Intercellular and intracellular communications depend to a significant degree on the interaction between different signaling proteins. Such interactions may be responsible for the initiation and progression of a variety of cellular processes. For example, proteinprotein interactions may induce conformational changes that stabilize, destabilize, or alter the enzymatic properties of the interacting partners (Goh et al., 2004) . Protein-protein interactions may also contribute to the formation of large molecular complexes that allow the coordinate response of multiple molecules to incoming signals (Stagljar, 2003) . Finally, some proteins may function as anchors that allow the association of their binding partners with certain cellular structures or may facilitate the transport of their partners between cellular compartments (Fowler and Alarid, 2004) . To accomplish these diverse outcomes, interacting proteins bind each other either constitutively or in a signal-dependent manner, and modify the activities of their interacting partners by providing either an adaptor or an enzymatic function. The realization that protein-protein interactions play a critical role in cell signaling led to the establishment of technologies that allowed the identification of networks of interacting proteins and revolutionized our understanding of cell function at the molecular level. These technologies also allowed the identification of a large array of protein-protein interaction motifs that facilitate our understanding of signal transduction by providing clues on the potential function of novel signaling proteins (Barnouin, 2004; Miller and Stagljar, 2004) .
Akt1, also known as protein kinase Ba (PKBa) (Bellacosa et al., 1991; Coffer and Woodgett, 1991; Jones et al., 1991) , is the founding member of a protein kinase family composed of three members, Akt1, Akt2, and Akt3. Akt family members regulate a diverse array of cellular functions, including apoptosis, cellular proliferation, differentiation, and intermediary metabolism (Chan et al., 1999) . Akt activation depends on PtdIns-3,4,5-P 3 , and to a lesser extent on PtdIns-3,4-P 2 , both of which are products of phosphoinositide 3-kinase (PI-3K) . The interaction of PtdIns-3,4,5-P 3 with the Pleckstrin homology (PH) domain of Akt promotes the translocation of Akt to the plasma membrane, where it undergoes phosphorylation at two sites, one in the activation loop (Thr308) and the other in the carboxy-terminal (C-terminal) tail (Ser473). Phosphorylation at Ser473 appears to precede and facilitate phosphorylation at Thr308 (Sarbassov et al., 2005 and references therein). The kinase that phosphorylates Akt at Thr308 is PI-3K-dependent kinase 1 (PDK1) (Chan et al., 1999) . The kinase that phosphorylates Akt at Ser473 (PDK2) had been elusive for many years. Recent studies revealed that in 293T cells and several carcinoma cell lines, Akt phosphorylation at this site depends on a complex that contains the mammalian target of rapamycin (mTOR), GbL, and rictor (Sarbassov et al., 2005) . Earlier studies had shown that several additional kinases, including ILK-1, PDK1, Akt itself, and perhaps other members of the AGC kinase family, as well as DNA-PK cs , may have the potential to phosphorylate Akt at this site (Chan and Tsichlis, 2001; Dong and Liu, 2005) . Although the role of the rictor-mTOR complex in the phosphorylation of Akt at Ser473 is beyond doubt, the potential involvement of these kinases in this process in some cells responding to specific signals has not been excluded today. Phosphorylated Akt may translocate from the plasma membrane to the cytosol or the nucleus (Meier et al., 1997; Meier and Hemmings, 1999) . Activated Akt ultimately undergoes dephosphorylation by phosphatases and returns to the inactive state (Meier et al., 1998) (Figure 1 ).
Given the functional importance of Akt, the search for the identification of its binding partners has been intense. Proteins interacting with Akt, and other kinases, include kinase substrates and kinase regulators. In this review, we will focus on the interaction of Akt with regulatory molecules. For the sake of clarity, Akt interacting proteins will be grouped based on the Akt domain they interact with (Figure 2 ).
Proteins interacting with the PH domain of Akt
The PH domain of Akt binds D3 PPIs and promotes the translocation of the kinase to the plasma membrane, a process that is critical for Akt activation (Chan et al., 1999) . However, the PH domain may also interact with Akt regulatory proteins. The earliest observation that the PH domain of Akt functions as a protein-protein interaction motif was presented in a paper showing that Akt oligomerizes and that oligomerization is PH domain-dependent .
Tcl1 and other members of the Tcl1 protein family
The Tcl1 oncogene on chromosome 14q32.1 is activated by chromosomal inversion or translocation ((Inv(14) (q11;q32) and t(14; 14) (q11;q32) or t(7; 14) (q35;q32)) in human T-cell leukemia (Virgilio et al., 1994) . Tcl1 encodes a 14-kDa protein whose crystal structure suggests that it may be involved in molecular transport, a function that may be relevant to its role in the regulation of the Akt kinase (Petock et al., 2002) . The Tcl1 gene is the founding member of a gene family that includes Tcl1 itself, MTCP-1, located on chromosome Xq28 (Gritti et al., 1997) and Tcl1b, located together with Tcl1, on chromosome 14q32.1 Pekarsky et al., 1999) . The latter is represented by at least five homologs in the mouse . All three genes have been shown to be involved in the induction of different forms of human T-cell leukemia P P P P P P P P
PIP3
PI3K P PDK1 Tyr376 Tyr373 Ser241 P P Thr308 Ser473 P P P P P P P P P (Teitell, 2005) . Moreover, Tcl1 and MTCP1 have been shown to induce lymphoid tumors when overexpressed in transgenic mice (Gritti et al., 1998; Virgilio et al., 1998) . Tcl1 and Tcl1b are expressed normally in early T-cell progenitors, in pre-B, and in immature lgMexpressing B cells (Pekarsky et al., , 2004 Teitell, 2005) . MTCP1 encodes 8-and 13-kDa proteins. Expression of the 13-kDa isoform has been detected only in T cells with a t(X;14) translocation (Madani et al., 1996) .
P
All three Tcl1 family members interact with Akt1 and Akt2. However, only Tcl1 interacts with all Akt isoforms, including Akt3 (Laine et al., 2002) . Tcl1 forms trimeric complexes and each of these complexes may interact with three molecules of Akt, resulting in Akt oligomerization (French et al., 2002) . Although Tcl1 may promote oligomerization of Akt, it should be remembered that Akt may oligomerize via PH domain binding in yeast, which lacks Tcl1 or other members of the Tcl1 family .
It is generally agreed that Tcl1-bound Akt in transfected cells exhibits higher stoichiometry of phosphorylation than unbound Akt (Laine et al., 2000; Pekarsky et al., 2000) . This suggests, but does not prove, that binding to Tcl1 may promote the activation of Akt. One group has provided evidence that binding to Tcl1 indeed activates Akt both in vitro and in vivo (Laine et al., 2000) . Although technically convincing, the in vitro data are somewhat difficult to interpret because they show that Tcl1-mediated Akt activation depends on the kinase activity of Akt and is independent of PDK1.
Based on information available today, we propose the following plausible model regarding the role of Tcl1 in Akt activation. Oligomerization of Akt promoted by Tcl1 may facilitate Akt phosphorylation at Ser473 by Akt itself, if one assumes that Akt can phosphorylate this site, or by another kinase such as mTOR (Sarbassov et al., 2005) . This may in turn promote conformational changes that facilitate phosphorylation at Thr308 by PDK1. This is consistent with the Akt2 structural data (Yang et al., 2002) and with the finding that the effects of Tcl1 are PI3K-dependent (Laine et al., 2000; Pekarsky et al., 2000) . The notion that the interaction of Tcl1 with the PH domain of Akt may abrogate the need for D3 PPI binding is not consistent with the PI-3K dependence of the Tcl1 effect.
In addition to activating Akt, Tcl1 also appears to promote the translocation of the activated Akt kinase into the nucleus (Pekarsky et al., 2000) . This suggests that Tcl1 may not only enhance the activity of the Akt kinase, but, by modulating its subcellular distribution, also affect the spectrum of Akt substrates.
Definition of the Tcl1 domain that interacts with the PH domain of Akt allowed the synthesis of a peptide that binds Akt and inhibits its activation by PDGF in 293 cells. This peptide inhibits the in vivo growth of the fibrosarcoma cell line QRsP-11 in syngeneic C57BL/6 mice (Hiromura et al., 2004) . Since 293 and QRsP-11 cells do not express Tcl1, this peptide may inhibit the activation of Akt by mechanisms that are independent of Tcl1. This illustrates that the interaction of Akt and Tcl1 may have provided clues for the design of a molecule that inhibits Akt by a wide range of signals.
JNK interacting protein 1 (JIP1)
JIP1 is a 660 amino-acid protein (707 amino acids (aa) for JIP1b), which is involved in the assembly of signaling complexes that contain JNK, MKK7, and MLK3 and is required for JNK activation (Yasuda et al., 1999; Whitmarsh et al., 2001) . It was recently shown that JIP1 also interacts specifically with the PH domain of Akt1. Through this interaction, Akt1 sequesters JIP1 and makes it unavailable for the assembly of JNK activation complexes. As a result, Akt1 inhibits JNK activation and apoptosis induced by the excitotoxin kainate in neuronal cells (Kim et al., 2002) . Early studies had shown that the disruption of the Akt1/JIP1 complex is not associated with a change in the Akt1 phosphorylation status and that both the wild-type and the kinase-inactive Akt1 inhibit the activation of JNK by kainate. These data were challenged by more recent studies showing that overexpression of JIP1 enhances the catalytic activity of Akt (Kim et al., 2003) or that JIP1 binding inhibits Akt (Song and Lee, 2005) . In either case, the interaction of JIP1 with Akt1 represents a novel mechanism by which Akt may regulate apoptosis.
Growth factor receptor-binding protein-10 (Grb10)
Grb10 is a member of a superfamily of adaptor proteins. Its closest relatives are Grb7 and Grb14. The proteins that belong to this family share a common overall structure, that is characterized by a conserved N-terminal proline-rich motif, a central PH domain, a C-terminal Src homology 2 (SH2) domain and a conserved region located between the PH and the SH2 domains (Between PH and SH2 (BPS)) (Lim et al., 2004) . Grb10 and Akt interact constitutively via their PH domains (Jahn et al., 2002) . Via its SH2 domain, Grb10 also binds phosphorylated tyrosine residues in several ligand-activated tyrosine kinase receptors, including the insulin receptor (IR), the insulin-like growth factor-I receptor (IGF-IR) and c-kit. The Grb10/Akt interaction contributes to Akt activation by growth factors. This is suggested by several observations. First, Grb10 and c-kit act synergistically to activate Akt. Additionally, a constitutively active mutant of c-kit, which lacks the binding site for PI-3K (c-kitD814V/Y719F) and does not activate Akt, can be fully complimented in Akt activation by overexpression of Grb10. As a result, whereas overexpression of c-kitD814V/Y719F does not render Ba/F3 cells IL-3 independent, coexpression of c-kitD814V/Y719F with wild type, but not an SH2 deletion mutant, of Grb10 does (Jahn et al., 2002) .
Ras GTPase-activating protein (RasGAP)
RasGAP, a negative regulator as well as a downstream effector of Ras (Scheffzek et al., 1997) , interacts with the PH domain of Akt and promotes Akt activation by serum. The ability of RasGAP to promote Akt activation is independent of its GAP activity as overexpression of a RasGAP mutant lacking the GTPase-activation domain enhanced the phosphorylation and basal activity of the Akt kinase and protected cardiomyocytes from staurosporin-induced apoptosis. Knockdown of endogenous RasGAP expression, by RasGAP shRNA, on the other hand, inhibited Akt phosphorylation, despite the fact that it also upregulated RAS GTP binding (Yue et al., 2004) . Given that RasGAP inhibits the activity of Ras, a small GTPase that activates PI-3K (Chan et al., 2002) , the activation of Akt by RasGAP may depend on how the two opposing functions of this protein are integrated in different physiological settings.
Other PH domain interacting proteins
Two additional proteins have been shown to interact with the PH domain of Akt: lnosine-5 0 monophosphate dehydrogenase (IMPDH), which interacts with the PH domain of Akt1 (Ingley and Hemmings, 2000) , and myosin II (Tanaka et al., 1999) . The physiological significance of these interactions remains to be determined.
Proteins interacting with the kinase domain

Cdc37/Hsp90
Heat shock protein-90 (Hsp90) is a molecular chaperone that facilitates protein folding and protects a variety of proteins from degradation during stress (Neckers and Ivy, 2003; Pearl, 2005) . Hsp90 forms a complex with the co-chaperone Cdc37 and the complex binds a variety of cellular proteins, including tyrosine and serine-threonine protein kinases (Grammatikakis et al., 1999; Richter and Buchner, 2001; Pearl, 2005) . One of these kinases is Akt, which interacts with the Cdc37/Hsp90 complex via its kinase domain (Basso et al., 2002a) . Disruption of this interaction with geldanamycin and other ansamycin antibiotics promotes protein degradation via the proteasome pathway, suggesting that the interaction of this complex with Akt protects Akt from degradation (Basso et al., 2002a) . It is interesting that, in tumor cell lines expressing a constitutively active tyrosine kinase receptor, treatment with low doses of ansamycin antibiotics does not induce Akt degradation, but specifically inhibits its activity. This may be caused by the ansamycin-induced degradation of the tyrosine kinase receptor, which may be more sensitive to changes in the stoichiometry of binding to the Cdc37/Hsp90 complex than Akt (Basso et al., 2002a, b) . The specificity of the inhibitory effect of ansamycin antibiotics toward Akt in these cell lines may be due to the sensitivity of Akt to tyrosine kinase receptor signals. Inhibition of Akt by ansamycin antibiotics suppresses cell cycle progression and promotes apoptosis. As a result, ansamycin antibiotics inhibit the growth of tumor cells both in culture and in animals, and represent promising chemotherapeutic agents.
Recent studies revealed that Hsp90 may exhibit higher affinity to Hsp90 ATPase inhibitors in tumor cells than in normal cells (Kamal et al., 2003; Vilenchik et al., 2004) . This finding may explain the higher susceptibility of tumor cells to these inhibitors (Bagatell and Whitesell, 2004) . The higher affinity of the Hsp90 inhibitors toward tumor Hsp90 could be caused by an increase in affinity of Cdc37 toward Hsp90 in tumor cells, which in turn may be caused by tumor-specific changes in the covalent state of Hsp90, or by modifications of Cdc37 or other Hsp90 co-chaperones. Structural studies have shown that Cdc37 binds at the mouth of the ATPbinding pocket of Hsp90 (Roe et al., 2004) . As a result, Cdc37 binding may reduce the 'off rate' of inhibitory molecules bound to the pocket and may effectively increase their apparent affinity toward Hsp90. One modification that may be more common in tumors than in normal cells is phosphorylation of Cdc37 at Ser13 by casein kinase II (CKII). Phosphorylation at this site has been shown to regulate the affinity of Cdc37 toward Hsp90 (Shao et al., 2003; Miyata and Nishida, 2004) . We speculate here that if Akt also phosphorylates components of the Hsp90 complex, it may contribute to the observed tumor-specific changes in the properties of the complex. We also suggest that modification of the complex by Akt will allow Akt to exert global effects on cell function.
Since the Cdc37/Hsp90 complex binds proteins other than Akt, it is possible that it may facilitate the interaction of Akt with some of the Akt substrates and the subsequent phosphorylation of these substrates. One protein whose phosphorylation by Akt may be facilitated by Hsp90 is endothelial nitric oxide synthase (eNOS) (Fontana et al., 2002) .
TRB3: a Tribbles homolog
TRB3 belongs a family of at least three known proteins, TRB1, TRB2, and TRB3, all of which harbor a variant kinase core motif, which lacks the ATP-binding site (TRB3 175-182 aa; LRDLKLRR vs consensus: HRDL KPEN). As a result, TRB proteins lack kinase activity (Du et al., 2003) . TRB proteins are similar to tribbles, a Drosophila protein that inhibits mitosis early in development by binding to the CDC25 homolog String and by promoting String ubiquitination and proteasomemediated degradation (Grosshans and Wieschaus, 2000) .
TRB3 (also known as NIPK) was originally cloned as a gene that is upregulated in neurons undergoing apoptosis induced by NGF withdrawal (MayumiMatsuda et al., 1999) . The interaction between TRB3 and Akt was first detected in the course of a yeast twohybrid screen designed to identify Akt-binding proteins. TRB3 binds the kinase domain of Akt in the activation loop, and inhibits its phosphorylation at both Thr308 and Ser473 by growth factors and insulin (Du et al., 2003) . The physiological relevance of the interaction between Akt and TRB3 is supported by recent findings showing that TRB3 expression is induced in normal liver following fasting, and that TRB3 levels are significantly higher in the liver of db/db diabetic mice than in the liver of wild-type mice. More important, whereas hepatic overexpression of TRB3 in amounts comparable to those in db/db mice induced glucose intolerance and hyperglycemia (Du et al., 2003) , knocking down TRB3 expression with RNAi in the liver of db/db mice, restored insulin responsiveness (Koo et al., 2004) . Owing to its involvement in the activation of Akt by external signals, TRB3 also contributes to the regulation of cell growth and apoptosis. Thus, whereas overexpression of TRB3 in different cell types is associated with a decrease in cell size and an enhancement in apoptosis (Ohoka et al., 2005) , downregulation of its expression by RNAi is associated with the inhibition of apoptosis induced by endoplasmic reticulum (ER) stress, growth factor withdrawal, and TNF-a (Wu et al., 2003; Ohoka et al., 2005) .
Mammalian TRB3 also interacts with several other proteins, including several members of the MAPK family (Kiss-Toth et al., 2004) and the transcription factors ATF4 (Bowers et al., 2003; Ord and Ord, 2003) , CHOP (Ohoka et al., 2005) , and NF-kB, while dTribbles also interacts with dC/EBP (Rorth et al., 2000) . Binding of TRB3 to these proteins generally inhibits their activities. Thus, TRB3 inhibits the transcriptional activities of ATF4 and CHOP (Ohoka et al., 2005) , as well as the PKA-induced transcriptional activity of NF-kB (Wu et al., 2003) . Regarding MAPKs, TRB3 may either upregulate or downregulate their activities, depending on its expression levels (Kiss-Toth et al., 2004) . TRB3 expression is induced by various stimuli, including hypoxia (Bowers et al., 2003) , TNF-a, and reagents that induce ER stress. In addition, it is induced in the liver, in the course of pathological syndromes, such as fatty degeneration (Klingenspor et al., 1999) and diabetes (Du et al., 2003) . In response to ER stress, ATF4 and CHOP bind to the TRB3 promoter and activate TRB3 gene expression (Bowers et al., 2003; Ohoka et al., 2005) . In fatty and diabetic liver, upregulation of TRB3 is mediated through PPARa. More recently, TRB3 expression in liver was also linked to PGC-1, a coactivator for PPARa and PPARg. PGC-1 overexpression induced TRB3 and hyperglycemia. Knocking down TRB3 by RNAi in PGC1-overexpressing livers partially inhibited hyperglycemia, suggesting that the induction of hyperglycemia by PGC1-is TRB3-dependent. These data suggest that, by interfering with the activation of Akt, TRB3 may contribute to insulin resistance in individuals with type II diabetes (Koo et al., 2004) .
As mentioned above, TRB3 belongs to a protein family that consists of three members. This raises several questions that remain to be addressed: (a) Do different members of the family interact with each other, and if they do, what is the biological significance of the resulting homodimers and heterodimers? (b) Is the interaction with Akt a unique property of TRB3, or a common property of all the members of the family? Another question that remains to be addressed is whether TRB proteins in different species are functionally equivalent. Evidence to date favors the hypothesis that the functions of these proteins in different species may be unique, although it is possible that they may also overlap. Thus, although mammalian TRB3 appears to promote apoptosis and to inhibit cell growth and proliferation, the Xenopus TRB2 protein (xTRB2) promotes cell proliferation. Moreover, xTRB2 cannot substitute for dTribbles during Drosophila development (Saka and Smith, 2004) . Finally, whereas dTribbles promotes proteosome-mediated degradation of its associated partners Cdc25 (Seher and Leptin, 2000) and C/EBP (Rorth et al., 2000) , there is no evidence that mammalian TRBs are involved in protein degradation.
Adaptor protein containing PH domain, PTB domain and Leucine zipper motif (APPL)
APPL1, the founding member of a two-member family, is a 710-aa protein that interacts with the kinase domains of Akt1 and Akt2 and with the catalytic subunit of type 1A PI-3K (p110a) (Mitsuuchi et al., 1999) . Whether the second member of the family (APPL2) interacts with Akt is currently unknown. APPL1 was mapped to human chromosome 3p4.1-21.1 and is highly expressed in skeletal muscle, heart, ovary, and pancreas. As indicated by its name, it contains a PH domain, a PTB domain and a putative leucine zipper domain. Its interaction with Akt2 is mediated by the PTB domain (Mitsuuchi et al., 1999; Yang et al., 2003) . Recent studies suggested that overexpression of APPL enhances Akt activation by IGF1 and promotes Akt-mediated suppression of androgen receptor transactivation (Yang et al., 2003) . The importance of APPL in the physiological regulation of Akt remains to be determined.
APPL1 also interacts with the small GTPase Rab5, a key regulator of endocytosis, and with a deacetylase multiprotein complex NuRD/MeCP1, which regulates chromatin structure and gene expression (Miaczynska et al., 2004) . APPL1 is localized in a subpopulation of endosomes (Miaczynska et al., 2004) . In response to stimuli such as EGF and oxidative stress, APPL1 associated with endosomes that contain both Rab5 and APPL1 translocates into the nucleus, where it interacts with NuRD/MeCP1. As a result, APPL1 is essential for cell growth in response to EGF. Finally, APPL1 (also known as DIP13a) also interacts with a region in the cytoplasmic domain of Deletion in Colon Cancer (DCC) and promotes DCC-induced apoptosis (Liu et al., 2002) . How the interaction of Akt with APPL1 modulates the effects of APPL1 on membrane trafficking, cell growth, gene expression, proliferation and apoptosis is currently unknown.
Proteins interacting with the C-terminal tail
C-terminal modulator protein (CTMP)
The human CTMP gene encodes a 240-aa protein that is expressed in skeletal muscle, testis uterus, brain and kidney with lower levels in heart liver and lung. In starved cells, CTMP is nonphosphorylated and is associated with the plasma membrane. CTMP, in its nonphosphorylated membrane-associated form, binds the C-terminal tail of Akt. Bound Akt, colocalizing with CTMP at the plasma membrane, is inactive. Exposure to external signals promotes the phosphorylation of CTMP and the release and activation of Akt (Maira et al., 2001) . However, it is not known whether the pool of Akt undergoing activation is the same pool that is bound to CTMP prior to stimulation.
Although CTMP clearly inhibits the activity of the Akt kinase, its physiological role in regulating Akt activation remains to be determined. It is generally thought that, in unstimulated cells, the majority of Akt is localized in the cytosol, where it is inactive, despite the fact that it is not bound to CTMP. Translocation to the membrane occurs following stimulation and it is associated with Akt phosphorylation and activation. It is possible that CTMP assembles a pool of catalytically inactive Akt at the plasma membrane and that this pool may be transported rapidly to membrane microdomains, where activation takes place following stimulation. If CTMP indeed assembles a rapidly accessible Akt pool, one would expect that CTMP would be required for Akt activation by physiological signals. However, this remains to be determined.
Akt phosphorylation enhancer (APE), or Hook-related protein-1 APE, also known as Hook-related protein-1 (HKRP1), is a 1847-aa protein with a coiled-coil domain and a putative microtubule-binding domain, which is believed to be involved in endosome trafficking (Simpson et al., 2005) .
APE specifically associates with the C-terminus of Akt (Anai et al., 2005) . Binding to APE enhances the basal phosphorylation of Akt. However, APE-induced phosphorylation of Akt requires PI-3K, as wortmannin or LY294002 inhibits APE-induced Akt activation. In addition, APE enhances and/or prolongs the PI-3K-dependent phosphorylation of Akt by external signals (Anai et al., 2005) . However, the molecular mechanism by which APE enhances the activity of Akt is not clear.
APE behaves as a DNA replication licensing factor. In cells in which APE was knocked down by RNAi, Akt phosphorylation and DNA synthesis were both significantly reduced. In cells overexpressing both Akt and APE, DNA replication was initiated and it was followed by Chk2 activation. DNA rereplication and Chk2 activation promoted apoptosis, despite the APEinduced marked increase in the basal phosphorylation of Akt (Anai et al., 2005) . The potential involvement of Akt in the licensing of DNA replication by APE has not yet been determined. In addition, it is not yet clear whether the activation of Akt by APE has the potential to alter the proapoptotic effects of the APE protein.
SH3 domain-containing proteins, Src and Arg-binding protein 2g (ArgBP2g)
In the C-terminus of Akt, there is a proline-rich region that harbors two PXXP motifs. Through these motifs, Akt can bind SH3 domain-containing proteins. The first such protein shown to interact with Akt is the tyrosine kinase Src. Bound Src may phosphorylate Akt at Tyr315 and may promote its activation by external signals (Chen et al., 2001) .
Although early studies failed to show that Akt undergoes tyrosine phosphorylation, more recent studies suggested that it does undergo phosphorylation on tyrosine in response to EGF stimulation. EGF-induced tyrosine phosphorylation of Akt is likely to be mediated by Src it was singificantly reduced in SYF cells lacking Src, Yes and Fyn, and a P424A/P427A double Akt mutant which does not bind Src, failed to undergo tyrosine phsphorylation upon stimulation with EGF. The same mutant failed to undergo activation in response to EGF, suggesting that phosphorylation by Src plays an important role in Akt activation by external signals (Jiang and Qiu, 2003) .
The other SH3 domain-containing protein that interacts with Akt is ArgBP2g, an adaptor protein that belongs to a four-member protein family (Kioka et al., 2002) . ArgBP2 (a and b) was first identified as a protein that interacts with the tyrosine kinases Arg and Abl (Wang et al., 1997) . ArgBP2g contains a SoHo (Sorbin Homology) motif and three SH3 domains (Kioka et al., 2002) . Through its SoHo motif, it binds to spectrin and may therefore regulate the actin cytoskeleton (Cestra et al., 2005) .
ArgBP2g binds the proline-rich C-terminal motifs of Akt via its first and second SH3 domains. In addition, it binds, the p21-activated protein kinase PAK1, via its first and third SH3 domains. As a result, it may contribute to the formation of Akt-ArgBPg-PAK1 complexes. Although the interaction between ArgBP2g and Akt does not affect the Akt kinase activity (Yuan et al., 2005) , it may contribute to in the regulation of PAK1 by Akt. ArgBP2g contains four Akt phosphorylation consensus sites that can be phosphorylated by Akt both in vitro and in vivo. Phosphorylation of ArgBP2g at these sites may contribute to the activation of PAK1 by Akt. Thus, the nonphosphorylatable ArgBP2g-4A mutant and a truncated mutant of ArgBP2g missing one of its SH3 domains inhibit the activation of PAK1 by Akt. The same mutants inhibit the phosphorylation of Bad by Akt and PAK1, and reduce the Akt and PAK1 antiapoptotic activities. Collectively, these findings indicate that the binding of ArgBP2g to both Akt and PAK1 and the phosphorylation of ArgBP2g by Akt are required for the activation of PAK1 by Akt and for the integrity of the Akt/PAK1 survival pathway (Yuan et al., 2005) .
Prohibitin 2 (PHB2)
Prohibitin 2, a protein that belongs to a two-member protein family, was originally identified as a 37-kDa protein that is associated with the intracellular domain of the mlgM class of antigen receptors in B cells (BAP37) (Terashima et al., 1994) . Prohibitin 2 is a highly conserved, ubiquitously expressed protein with homologs in bacteria, yeast, plants, Drosophila, and mammals (Nijtmans et al., 2002) . Prohibitins 1 and 2 are both components of a large complex that is associated with the mitochondrial inner membrane (Nijtmans et al., 2000) . Moreover, prohibitin interacts with Rb and E2F, represses the transcriptional activity of E2F and inhibits cellular proliferation (Wang et al., 1999 .
Akt interacts with prohibitin 2 (120-232 aa) via its C-terminal tail (413-480 aa). The interaction of the two proteins was originally detected in a yeast two-hybrid screen in which the bait was full-length Akt (Sun et al., 2004) . Prohibitin also interacts with MyoD, and MEF2, and represses their transcriptional activities. The binding of Akt to prohibitin relieves the prohibitin-mediated repression of chromatin-associated transcriptional regulators. Thus, Akt promotes myogenic differentiation, perhaps by relieving the prohibitin-mediated repression of MyoD and MEF2 (Sun et al., 2004) .
3-Phosphoinositde dependent protein kinase-1 (PDK1)
As mentioned in the introduction, phosphorylation of Akt at Ser473 appears to precede phosphorylation by PDK1 at Thr308 (Sarbassov et al., 2005 , and references therein). More important, the S473D mutant of Akt and Akt phosphorylated at Ser473 by the rictor-mTOR complex are better targets of PDK1 than nonphosphorylated Akt (Sarbassov et al., 2005) . These findings suggest that phosphorylation at Ser473 may provide a docking site for PDK1.
The interaction of PDK1 with the phosphorylated hydrophobic motif of Akt is supported by a host of earlier observations. Thr308 and Ser473 phosphorylation sites are separated by 165 aa. The arrangement of two phosphorylation sites, one in the activation loop and the other in a hydrophobic motif in the kinase tail, is a common feature of the AGC kinase family, to which Akt belongs (Peterson and Schreiber, 1999) . Some of these kinases, including Protein Kinase C-related Kinase-2 (PRK2), contain a hydrophobic motif in which the phosphorylatable moiety has been substituted with aspartic acid. PRK2 interacts via this motif with PDK1 (Balendran et al., 1999 (Balendran et al., , 2000 . A peptide that spans the phosphomimetically altered hydrophobic motif of PRK2 continues to bind PDK1 and it is known as the PDK1-interacting fragment (PIF) (Balendran et al., 1999) . The PDK1 motif that binds PIF is known as the PIF-binding pocket (Biondi et al., 2001; Collins et al., 2003) . More recent studies demonstrated that, through this motif, PDK1 also binds AGC kinases other than PRK2, following phosphorylation of their hydrophobic motifs. For two such kinases, p70S6K and SGK, phosphorylation at this site appears to be essential for activation loop phosphorylation (Collins et al., 2003; Mora et al., 2004) . For Akt it is not essential, although it facilitates Thr308 phosphorylation by PDK1 (Sarbassov et al., 2005 , and references therein), suggesting that it may promote the Akt-PDK1 interaction (Balendran et al., 1999) .
Proteins for which the Akt domain they interact with has not been determined
Keratin-10
Keratin-10 is a component of a intermediate filament cytoskeleton, which imparts mechanical integrity to epithelial cells. Keratin-10 is expressed in postmitotic differentiating keratinocytes in vivo and its expression is severely reduced in proliferating cells, including neoplastic cells derived from cutaneous tumors (Siegel and Howard, 2002) . Keratin-10 binds PKCzeta and Akt via its N-terminus (Paramio et al., 2001) . However, the domain of Akt that interacts with keratin-10 is unknown.
Binding to keratin-10 sequesters Akt to the cytoskeleton and inhibits its translocation to the plasma membrane. As a result, the binding of keratin-10 to Akt inhibits Akt activation. Inhibition of Akt by keratin-10 interferes with the induction of cyclin D1 via E2F. Targeting a human keratin-10 transgene via the bovine keratin-5 promoter to the basal layer of the epidermis in mice resulted in impaired activation of Akt and in decreased proliferation and hypoplasia of the epidermis (Santos et al., 2002) .
Intramolecular Akt interactions
The crystal structure of Akt2 (Yang et al., 2002; Huang et al., 2003) suggests a model that addresses the molecular mechanism by which phosphorylation promotes the activation of Akt. According to this model, phosphorylation of Akt2 at Ser474 (equivalent to Ser473 in Akt1) promotes the interaction of the hydrophobic motif with the N-terminal lobe of the kinase and the transition of the aC helix from a disordered to an ordered state (Yang et al., 2002) . This transition, in turn, facilitates the interaction of the aC helix with the phosphorylated Thr309 moiety (equivalent to Thr308 in Akt1), and the restructuring of the activation loop of the kinase (Huang et al., 2003) . Based on this model, hydrophobic motif phosphorylation should be critical for Akt activation. Experimental data however, indicate that although hydrophobic motif phosphorylation contributes to, it is not required for Akt activation (Bellacosa et al., 1998) . One potential explanation for this discrepancy is that Akt may interact with the phosphorylated or phosphomimetically altered hydrophobic motifs of other AGC kinases and that such interactions may be functionally equivalent with the intramolecular interaction between the hydrophobic motif and the N-terminal lobe of the Akt kinase described above. However, this remains to be determined.
Summary
This review focuses on proteins that interact with Akt and may modulate its activity. The Akt interacting proteins were grouped based on the Akt domain they interact with. For some of these proteins, their role in Akt activation by physiological signals is clearly established, while for others it remains tentative. The interaction of Akt with two of these proteins (Cdc37/Hsp90 and Tcl1) led to the discovery of Akt inhibitors, which are currently at various stages of development.
